Company news
Pulmonx Corporation (NASDAQ:LUNG) news
Pulmonx Corporation news releases on 6ix. Latest, Aug 27, 2026: Pulmonx to Participate in Upcoming Investor Conferences
Press releases & updates
Pulmonx to Participate in Upcoming Investor Conferences
August 27, 2026
Pulmonx Reports Second Quarter 2026 Financial Results
July 29, 2026
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
July 15, 2026
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026
Pulmonx Reports First Quarter 2026 Financial Results
April 29, 2026
Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference
April 28, 2026
Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
April 15, 2026
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
March 3, 2026
Pulmonx Announces Closing of up to $60 Million Credit Facility
March 3, 2026
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
February 20, 2026
Magnolia Medical Welcomes Sarah Huber as Senior Vice President, Sales
February 12, 2026
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 3, 2025
Pulmonx Reports Third Quarter 2025 Financial Results
November 12, 2025
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
October 27, 2025
Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
October 15, 2025
Jaeger™ and Pulmonx Announce Strategic Partnership to Integrate Data Qualification Capabilities into SentrySuite™
August 27, 2025
Pulmonx to Participate in September Investor Conferences
August 26, 2025
Pulmonx Reports Second Quarter 2025 Financial Results
July 30, 2025
Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
July 29, 2025
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025
July 16, 2025
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
May 28, 2025
Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
May 1, 2025
Pulmonx Reports First Quarter 2025 Financial Results
April 30, 2025
Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025
April 16, 2025
Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
February 19, 2025
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
November 18, 2024
Pulmonx Reports Third Quarter 2024 Financial Results
October 29, 2024
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
October 15, 2024
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
September 8, 2024
Pulmonx Reports Second Quarter 2024 Financial Results
July 30, 2024
Pulmonx Reports First Quarter 2024 Financial Results
April 30, 2024
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
April 9, 2024
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
April 1, 2024
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
February 25, 2024
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
February 20, 2024
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
February 20, 2024
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
February 6, 2024
Pulmonx Reports Record Third Quarter 2023 Financial Results
October 29, 2023
Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
October 15, 2023
Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
October 9, 2023
Pulmonx Reports Second Quarter 2023 Financial Results
August 1, 2023
Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023
July 16, 2023
Pulmonx Reports First Quarter 2023 Financial Results
May 1, 2023
Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023
April 17, 2023
Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
November 29, 2022
Pulmonx Reports Third Quarter 2022 Financial Results
November 2, 2022
Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022
October 19, 2022
Pulmonx Reports Second Quarter 2022 Financial Results
August 1, 2022